Burek M - Search Results

1

Senescence and associated blood-brain barrier alterations in vitro.

Salvador E, Burek M, Löhr M, Nagai M, Hagemann C, Förster CY. Salvador E, et al. Among authors: burek m. Histochem Cell Biol. 2021 Sep;156(3):283-292. doi: 10.1007/s00418-021-01992-z. Epub 2021 May 27. Histochem Cell Biol. 2021. PMID: 34043058 Free PMC article.

2

Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system.

Förster C, Silwedel C, Golenhofen N, Burek M, Kietz S, Mankertz J, Drenckhahn D. Förster C, et al. Among authors: burek m. J Physiol. 2005 Jun 1;565(Pt 2):475-86. doi: 10.1113/jphysiol.2005.084038. Epub 2005 Mar 24. J Physiol. 2005. PMID: 15790664 Free PMC article.

3

Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific.

Förster C, Waschke J, Burek M, Leers J, Drenckhahn D. Förster C, et al. Among authors: burek m. J Physiol. 2006 Jun 1;573(Pt 2):413-25. doi: 10.1113/jphysiol.2006.106385. Epub 2006 Mar 16. J Physiol. 2006. PMID: 16543270 Free PMC article.

4

Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Förster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D. Förster C, et al. Among authors: burek m. J Physiol. 2008 Apr 1;586(7):1937-49. doi: 10.1113/jphysiol.2007.146852. Epub 2008 Feb 7. J Physiol. 2008. PMID: 18258663 Free PMC article.

5

Cloning and characterization of the murine claudin-5 promoter.

Burek M, Förster CY. Burek M, et al. Mol Cell Endocrinol. 2009 Jan 27;298(1-2):19-24. doi: 10.1016/j.mce.2008.09.041. Epub 2008 Oct 18. Mol Cell Endocrinol. 2009. PMID: 18996436

6

Claudin-5 as a novel estrogen target in vascular endothelium.

Burek M, Arias-Loza PA, Roewer N, Förster CY. Burek M, et al. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):298-304. doi: 10.1161/ATVBAHA.109.197582. Epub 2009 Nov 12. Arterioscler Thromb Vasc Biol. 2010. PMID: 19910637

7

Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome.

Kleinschnitz C, Blecharz K, Kahles T, Schwarz T, Kraft P, Göbel K, Meuth SG, Burek M, Thum T, Stoll G, Förster C. Kleinschnitz C, et al. Among authors: burek m. Stroke. 2011 Apr;42(4):1081-9. doi: 10.1161/STROKEAHA.110.592238. Epub 2011 Feb 17. Stroke. 2011. PMID: 21330632

8

Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells.

Neuhaus W, Burek M, Djuzenova CS, Thal SC, Koepsell H, Roewer N, Förster CY. Neuhaus W, et al. Among authors: burek m. Neurosci Lett. 2012 Jan 6;506(1):44-9. doi: 10.1016/j.neulet.2011.10.045. Epub 2011 Oct 21. Neurosci Lett. 2012. PMID: 22040671 Free article.

9

Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.

Burek M, Salvador E, Förster CY. Burek M, et al. J Vis Exp. 2012 Aug 29;(66):e4022. doi: 10.3791/4022. J Vis Exp. 2012. PMID: 22951995 Free PMC article.

10

1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier.

Prinz M, Parlar S, Bayraktar G, Alptüzün V, Erciyas E, Fallarero A, Karlsson D, Vuorela P, Burek M, Förster C, Turunc E, Armagan G, Yalcin A, Schiller C, Leuner K, Krug M, Sotriffer CA, Holzgrabe U. Prinz M, et al. Among authors: burek m. Eur J Pharm Sci. 2013 Jul 16;49(4):603-13. doi: 10.1016/j.ejps.2013.04.024. Epub 2013 May 2. Eur J Pharm Sci. 2013. PMID: 23643737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page